INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
Public company

TECXTectonic Therapeutic, Inc.

CIK 0001681087

EDGAR filingsOpen in network
Disclosed transactions46
Buys / sells0 / 11
Max Insider Score23
Connections9with evidence

TECX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
RA
Reicin AliseDirector, Chief Executive Officer
TECXTectonic Therapeutic, Inc.
Option exercise
M—
10.0K sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Reicin AliseDirector, Chief Executive Officer · Oct 28, 2026
  • ← Insider ofevidence
    Lochner DanielChief Financial Officer · Sep 8, 2026
  • ← Insider ofevidence
    Tipirneni Praveen P.Director · Jun 10, 2026
9
RA
Reicin AliseDirector, Chief Executive Officer
TECXTectonic Therapeutic, Inc.
Option exercise
M
$24K
10.0K sh
Oct 26, 2026
Oct 28, 2026
traded Oct 26, 2026
+2d
SEC FORM 4

Evidence

11
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Tax withholding
F$12K
525 sh
Sep 25, 2026Oct 2, 2026
traded Sep 25, 2026
+7dSEC FORM 4

Evidence

15
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Tax withholding
F$9,728
411 sh
Sep 25, 2026Oct 2, 2026
traded Sep 25, 2026
+7dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Tax withholding · 10b5-1 plan
F$11K
444 sh
Sep 25, 2026Oct 2, 2026
traded Sep 25, 2026
+7dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
536 sh
Sep 30, 2026Oct 2, 2026
traded Sep 30, 2026
+2dSEC FORM 4

Evidence

8
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
21.0K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

15
LD
Lochner DanielChief Financial Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
24.3K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

15
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
17.8K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

11
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
24.3K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M$633
43 sh
Aug 25, 2026Aug 26, 2026
traded Aug 25, 2026
+1dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M—
43 sh
Aug 25, 2026Aug 26, 2026
traded Aug 25, 2026
+1dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$1,570
43 sh
Aug 25, 2026Aug 26, 2026
traded Aug 25, 2026
+1dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M—
43 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M$633
43 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

1
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$1,505
43 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M$2,530
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M—
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

1
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$6,020
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
CC
Chutter Jessica CarolineDirector
TECXTectonic Therapeutic, Inc.
Grant or award
A—
20.4K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC FORM 4

Evidence

9
VS
Vitorovic StefanDirector
TECXTectonic Therapeutic, Inc.
Grant or award
A—
10.2K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC FORM 4

Evidence

9
TP
Tipirneni Praveen P.Director
TECXTectonic Therapeutic, Inc.
Grant or award
A—
10.2K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC FORM 4

Evidence

1
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
1,065 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

1
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

6
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$7,525
215 sh
Mar 6, 2026Mar 9, 2026
traded Mar 6, 2026
+3dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M$3,163
215 sh
Mar 6, 2026Mar 9, 2026
traded Mar 6, 2026
+3dSEC FORM 4

Evidence

13
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$181K
6,047 sh
Mar 6, 2026Mar 9, 2026
traded Mar 6, 2026
+3dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M$5,950
2,500 sh
Mar 6, 2026Mar 9, 2026
traded Mar 6, 2026
+3dSEC FORM 4

Evidence

20
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$300K
10.0K sh
Mar 6, 2026Mar 9, 2026
traded Mar 6, 2026
+3dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M—
215 sh
Mar 6, 2026Mar 9, 2026
traded Mar 6, 2026
+3dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M—
2,500 sh
Mar 6, 2026Mar 9, 2026
traded Mar 6, 2026
+3dSEC FORM 4

Evidence

17
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
26.5K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

10
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
1,649 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

7
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Grant or award · 10b5-1 plan
A—
23.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

6
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,650 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Grant or award · 10b5-1 plan
A—
21.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

21
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
19.5K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

9
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
17.8K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

9
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
24.3K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

17
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Option exercise
M$11K
4,500 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

13
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Option exercise
M—
4,500 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

19
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Tax withholding
F$38K
1,619 sh
Feb 4, 2026Feb 10, 2026
traded Feb 4, 2026
+6dSEC FORM 4

Evidence

15
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Tax withholding
F$48K
2,064 sh
Feb 4, 2026Feb 10, 2026
traded Feb 4, 2026
+6dSEC FORM 4

Evidence

15
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Tax withholding
F$41K
1,748 sh
Feb 4, 2026Feb 10, 2026
traded Feb 4, 2026
+6dSEC FORM 4

Evidence

23
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise
M$21K
7,000 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC FORM 4

Evidence

23
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise
M—
7,000 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Chutter Jessica CarolineDirector · Jun 10, 2026
  • ← Insider ofevidence
    Vitorovic StefanDirector · Jun 10, 2026
  • ← Insider ofevidence
    Ruddy Marcella K.Chief Medical Officer · Feb 10, 2026
  • ← Insider ofevidence
    Schwabish MarcChief Business Officer · Feb 10, 2026
  • ← Insider ofevidence
    McNamara PeterChief Scientific Officer · Dec 29, 2025